Why Viking Therapeutics Stock Skyrocketed on Tuesday
Key PointsParticipants in a maintenance study of VK2735 maintained up to 97% of their weight loss after 12 weeks.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.